Weiyuan Li

1.3k total citations
50 papers, 833 citations indexed

About

Weiyuan Li is a scholar working on Computer Networks and Communications, Molecular Biology and Cancer Research. According to data from OpenAlex, Weiyuan Li has authored 50 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Computer Networks and Communications, 11 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Weiyuan Li's work include Cancer-related molecular mechanisms research (6 papers), Caching and Content Delivery (6 papers) and IoT and Edge/Fog Computing (5 papers). Weiyuan Li is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Caching and Content Delivery (6 papers) and IoT and Edge/Fog Computing (5 papers). Weiyuan Li collaborates with scholars based in China, Singapore and Sweden. Weiyuan Li's co-authors include Hua Xu, Xuexin Li, Zehuan Liao, Mina Wang, Wenyan Cong, Li Niu, Liu Liu, Liqing Zhang, Wei Wang and Chunjie Xiao and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Controlled Release.

In The Last Decade

Weiyuan Li

47 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiyuan Li China 15 158 137 115 114 108 50 833
Hua Jiang China 16 265 1.7× 130 0.9× 94 0.8× 34 0.3× 82 0.8× 50 688
Xuewei Li China 16 91 0.6× 72 0.5× 56 0.5× 168 1.5× 64 0.6× 53 672
Jiachen Chen United States 18 169 1.1× 46 0.3× 411 3.6× 72 0.6× 188 1.7× 53 986
Matthew T. Dickerson United States 19 284 1.8× 69 0.5× 32 0.3× 135 1.2× 89 0.8× 82 1.1k
Xuan Tan China 12 89 0.6× 71 0.5× 30 0.3× 23 0.2× 271 2.5× 33 598
Ziteng Chen China 15 70 0.4× 124 0.9× 261 2.3× 27 0.2× 113 1.0× 32 663
Ruru Zhang China 11 46 0.3× 59 0.4× 158 1.4× 22 0.2× 110 1.0× 38 472
Huanle Zhang China 13 144 0.9× 173 1.3× 179 1.6× 52 0.5× 42 0.4× 45 692

Countries citing papers authored by Weiyuan Li

Since Specialization
Citations

This map shows the geographic impact of Weiyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyuan Li more than expected).

Fields of papers citing papers by Weiyuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyuan Li. The network helps show where Weiyuan Li may publish in the future.

Co-authorship network of co-authors of Weiyuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyuan Li. A scholar is included among the top collaborators of Weiyuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyuan Li. Weiyuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Meng, Kai, et al.. (2025). A novel peptide TCL6148 induces ferroptosis via the GOT1/GPX4 pathway to enhance sunitinib sensitivity in renal cell carcinoma. International Journal of Biological Macromolecules. 313. 144242–144242. 1 indexed citations
3.
Li, Weiyuan, et al.. (2025). Chrysin enhances sunitinib sensitivity in renal cell carcinoma by inducing ferroptosis via targeting PI3K/Akt/GPX4 pathway. Toxicology and Applied Pharmacology. 504. 117531–117531.
4.
Zhang, Yuxin, et al.. (2025). Gingerenone A inhibits LDHA-mediated glycolysis and restores sunitinib sensitivity in renal cell carcinoma. Biochemical Pharmacology. 243(Pt 2). 117563–117563.
5.
Li, Xuexin, Lu Pan, Weiyuan Li, et al.. (2025). Deciphering immune predictors of immunotherapy response: A multiomics approach at the pan-cancer level. Cell Reports Medicine. 6(4). 101992–101992. 7 indexed citations
6.
Yan, Guo, Jiacong Yan, Weiyuan Li, et al.. (2024). Correlation between viral infections in male semen and infertility: a literature review. Virology Journal. 21(1). 167–167. 7 indexed citations
7.
Wang, Shengyu, et al.. (2024). Recent Advances in Photodynamic Therapy for Vascular Abnormalities. Photobiomodulation Photomedicine and Laser Surgery. 42(8). 501–508. 1 indexed citations
8.
Li, Weiyuan, Lu Pan, Weifeng Hong, et al.. (2024). A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint blockade. Nature Communications. 15(1). 6142–6142. 12 indexed citations
9.
Chen, Bin, He Xu, Weiyuan Li, et al.. (2024). LncRNA MEG3 suppresses erastin-induced ferroptosis of chondrocytes via regulating miR-885-5p/SLC7A11 axis. Molecular Biology Reports. 51(1). 139–139. 11 indexed citations
10.
Tian, Bo, Xiaolu Li, Weiyuan Li, et al.. (2024). CRYAB suppresses ferroptosis and promotes osteogenic differentiation of human bone marrow stem cells via binding and stabilizing FTH1. Aging. 16(10). 8965–8979. 17 indexed citations
11.
Yan, Hongwei, Jinfeng Chen, Rui Gao, et al.. (2024). Comparative transcriptome analysis identified genes involved in ovarian development in Takifugu rubripes. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 54. 101407–101407. 1 indexed citations
12.
Yan, Hongwei, Weiyuan Li, Huiting Zhou, et al.. (2023). Estrodiol-17β and aromatase inhibitor treatment induced alternations of genome-wide DNA methylation pattern in Takifugu rubripes gonads. Gene. 882. 147641–147641. 2 indexed citations
14.
Li, Xuexin, Weiyuan Li, Mina Wang, & Zehuan Liao. (2021). Magnetic nanoparticles for cancer theranostics: Advances and prospects. Journal of Controlled Release. 335. 437–448. 136 indexed citations
15.
Li, Weiyuan, et al.. (2021). IoT Devices Identification Based on Machine Learning. 2021 IEEE 21st International Conference on Communication Technology (ICCT). 41. 770–777. 2 indexed citations
16.
Wang, Lei, Chunyan Yang, Fangfang Li, et al.. (2020). High levels of MESP1 expression in non-small cell lung cancer can facilitate cell proliferation, metastasis and suppresses cell apoptosis. Translational Cancer Research. 9(10). 5956–5968. 3 indexed citations
17.
Li, Ze, Hui Gao, Yang Liu, et al.. (2020). Genetic variants in the regulation region of TLR4 reduce the gastric cancer susceptibility. Gene. 767. 145181–145181. 13 indexed citations
18.
Cong, Wenyan, Jianfu Zhang, Li Niu, et al.. (2019). Deep Image Harmonization via Domain Verification.. arXiv (Cornell University). 1 indexed citations
19.
Li, Weiyuan, et al.. (2015). A dominating-set-based and popularity-driven caching scheme in edge CCN. 1–2. 4 indexed citations
20.
Hsu, Dar-Zu, Chia-Chien Wei, Hsing-Yu Chen, Weiyuan Li, & Jyehong Chen. (2011). Long-reach OFDM PON. 34–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026